Picard Medical adds two board members following IPO

Picard Medical, Inc. (NYSE American: PMI) appointed Sam Van and George Ye to its board of directors following the completion of its initial public offering, according to a company statement.

Van serves as founder and CEO of SRO Partners and previously held senior positions at Freedom U.S. Markets, a division of Freedom Holding Corp. (NASDAQ: FRHC), and the New York Stock Exchange, where he originated more than 60 new listings as Director of International Listings. He holds an MBA from Cornell University and a BS in Finance from St. John's University.

Ye brings medical device industry experience from his tenure at Edwards Lifesciences (NYSE: EW), where he served as Senior Vice President and General Manager for the Greater China Region and held other senior roles. He previously worked at Abbott Laboratories and Johnson & Johnson. Ye earned a Bachelor of Science in Chemical Engineering and an MBA from Northwestern University.

Picard Medical is the parent company of SynCardia Systems LLC, which manufactures the SynCardia Total Artificial Heart. The device has received approval from the FDA and Health Canada and has been implanted more than 2,100 times at hospitals across 27 countries.

The Tucson, Arizona-based company completed its initial public offering recently, transitioning to public company status on the NYSE American exchange.

You May Also Be Interested In